This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MetLife (MET) Up 12.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Trading Near 52-Week High, Why Allstate Stock is Still Worth Buying
by Zacks Equity Research
ALL's strong cash flow generation supports leverage improvement and shareholder returns.
THG Stock Up 34.4% YTD: Time to Add to Your Portfolio for Better Return?
by Zacks Equity Research
Hanover Insurance stands to gain from growth in the Core Commercial and Specialty segments, stable retention, better pricing, strong market presence and solid capital position.
Here's How Insurance ETFs Are Placed Post Q3 Earnings
by Sweta Killa
A slew of solid earnings from leading players in the insurance industry adds to the strength of the space.
Assurant Q3 Earnings Beat on Solid Global Housing Growth, View Raised
by Zacks Equity Research
AIZ's Q3 results reflect solid performance at Global Housing with growing revenues and expense discipline.
EverQuote Q3 Earnings, Revenues Top on Strong Automotive Vertical
by Zacks Equity Research
EVER's Q3 results reflect solid performances across Automotive insurance and Home and Renters insurance verticals, partially offset by higher expenses.
Everest Group Q3 Earnings, Revenues Miss on Higher Catastrophe Loss
by Zacks Equity Research
EG's Q3 results reflect above-average cat loss as well as lower premiums in Insurance. Higher premiums in Reinsurance and improved net investment income limited the downside.
Company News for Nov 1, 2024
by Zacks Equity Research
Companies In The Article Are: MET,CI, BMY, MO
MetLife Q3 Earnings Miss on Weak Group Benefits Unit & High Costs
by Zacks Equity Research
MET's third-quarter earnings suffer from higher expenses and a lower recurring interest margin in RIS.
Compared to Estimates, MetLife (MET) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MetLife (MET) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -10.65% and 4.66%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
MetLife Stock Before Q3 Earnings: Buy Now or Wait for Results?
by Zacks Equity Research
MET's third-quarter earnings are likely to have benefited from rising premiums and investment income.
Q3 Showdown: Can These 5 Insurance Stocks Beat the Estimates?
by Kaibalya Pravo Dey
Increasing rates, underwriting practices and other factors are expected to have benefited insurance players in the third quarter. AFL, MET, ALL, PRU & AXS will release earnings on Oct. 30.
5 Insurers Poised to Outperform Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help BRK.B, MET, LNC, WTW and AFL outperform third-quarter earnings estimates.
Exploring Analyst Estimates for MetLife (MET) Q3 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for MetLife (MET), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
MetLife (MET) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
This is Why MetLife (MET) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
THG Stock Trading at a Premium to Industry: Should You Buy?
by Tanuka De
THG stands to gain from growth in the Core Commercial and Specialty segments, stable retention, better pricing, strong market presence and solid capital position.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for EUSA
MetLife (MET) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
PRI Near 52-Week High: Should You Add the Stock to Your Portfolio Now?
by Zacks Equity Research
Primerica's strong licensed sales force, ensuring sales growth and policy persistency, and decision to exit the senior health market poise it well for growth.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.